SOLUGEN INC for SOLUGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Support the use of bio-based chemicals in the Department of Defense, generally. (S. 4638) FY 2025 National Defense Authorization Act, educate and advocate for secure supply chains. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY HOLBROOK | — |
| BRYAN J. SOUKUP | — |
Environment/Superfund ENV
Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Monitor implementation of (P.L.117-58), Infrastructure Investment and Jobs Act. Monitor implementation of (P.L. 117-169), Inflation Reduction Act. Monitor implementation of (Executive Order: 14081) Executive Order on Advancing Biotechnology and Biomanufacturing. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-18) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY HOLBROOK | — |
| BRYAN J. SOUKUP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.